Department of the Army April 18, 2005 – Federal Register Recent Federal Regulation Documents
Results 1 - 2 of 2
Armed Forces Institute of Pathology Scientific Advisory Board
In accordance with 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463) announcement is made of the following open meeting: Name of Committee: Scientific Advisory Board (SAB). Dates of Meeting: May 19-20, 2005. Place: The Armed Forces Institute of Pathology, 14th St. & Alaska Ave., NW., Building 54, Washington, DC 20306-6000. Time: 8:30 a.m.-4:45 p.m. (May 19, 2005). 8 a.m.-12 p.m. (May 20, 2005).
Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Prophylactic and Therapeutic Monoclonal Antibodies
In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of U.S. Patent Application No. 10/987,533 entitled ``Prophylactic and Therapeutic Monoclonal Antibodies,'' filed November 12, 2004. Foreign rights are also available (PCT/US04/38480). The United States Government, as represented by the Secretary of the Army, has rights in this invention.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
